These box office numbers do not include the cost of production or marketing costs. They also don't count the billions in merchandising that Disney has made over the last...Entertainmentread more
Instagram began tests that hide "like" counts on posts. That means influencers who market products on Instagram will have to rely on different metrics to show success.Technologyread more
Peter Neupert worked for Microsoft and Amazon-backed Drugstore.com, where he got to know Jeff Bezos. He now advises start-ups.Technologyread more
Facebook Vice President David Marcus is the face of the company's Libra digital currency, but the original driving force was a 26-year-old female corporate-development...Technologyread more
Regional stability, oil prices and potential for war will all depend on what Iran does with its nuclear program in the event of the deal's termination.World Politicsread more
The firing of the tear gas was the latest confrontation between police and protesters who have taken to the streets for over a month to fight a proposed extradition bill and...China Politicsread more
Amazon's new policy for account suspensions doesn't go far enough to protect sellers from potentially unfair and wrongful suspensions, merchants say.Technologyread more
There is no end in sight to the Boeing 737 Max grounding after two fatal crashes, prompting airlines to rethink their growth plans.Airlinesread more
After a year of flooding, Midwest farmers face a stifling heat wave that's spreading across the U.S.Weather & Natural Disastersread more
On Saturday, Disney's Marvel Studios announced its upcoming slate of superhero films during a panel at San Diego Comic-Con.Entertainmentread more
"It troubles me that the most important political office in the world is becoming the face of racism and exclusion," Kaeser said in a Twitter post.Politicsread more
Indianapolis drug giant Eli Lilly raised list prices of nine of its medicines last week between 6 and 10 percent, according to data obtained by CNBC.
The increases, taken on May 2, were for drugs including the blood thinner Effient (9.9 percent), the psoriasis drug
The increases fit a pattern at Lilly and many other drugmakers of single-digit percentage hikes once or twice a year, despite political pressure and intense scrutiny of the practices. Lilly has come under fire for the price of its insulin
Lilly confirmed the price increases in an emailed statement to CNBC, and noted the list prices "do not reflect the significant discounts and rebates that we provide to ensure patients have adequate access to our medicines."
"The net price increase that Lilly recognizes is significantly less," spokesman Mark Taylor wrote. "In fact, in 2016, the average discount to list price on our U.S. portfolio rose to 50 percent and net prices rose just 2.4 percent in the U.S."
Rebates on list prices of medicines are negotiated by pharmacy benefits managers. Drugmakers argue few patients are exposed to the list prices of medicines because of these discounts and rebates.
One of the largest pharmacy benefits managers, Express Scripts, announced this week a program to offer lower drug prices to patients without health insurance or who have high-deductible plans that make out-of-pocket costs for medicines untenable.
Lilly's chief executive, Dave Ricks, appeared on CBS This Morning with Express Scripts Chief Tim Wentworth to praise the program, called Inside Rx.
"We wake up every day trying to invent new medicines and get them to people who are sick," Ricks said. "This initiative… is
Lilly's product Humalog is included in the program, Ricks said. Outside of programs like this one, patients without insurance generally don't get access to the
"When people go to the pharmacy counter and have that sticker shock, often they do walk away," Ricks said. "This, maybe, can bridge some people to fill their prescription, control their diabetes a little better. I think everyone's better off in that system."
Lilly took list price increases on those medicines of between 18 and 24 percent in 2014, 17 and 32 percent in 2015, and 7.5 and 21 percent in 2016, according to analysts at Bernstein Research, who confirmed the recent 2017 increases as well.
When pricing its products, Lilly takes into account "the value they bring to patients and the healthcare system, as well as current marketplace conditions and the need to fund the development of the next generation of innovative medicines," Taylor said.
Amid heightened political scrutiny of drug prices, many manufacturers have pledged to curb increases. Allergan said it plans to keep price increases to less than 10 percent a year, sticking to 9.5 percent for a number of its drugs in 2017.
The pledges come as President Donald Trump has maintained a focus on the issue, saying the pharmaceutical industry is "getting away with murder" when it comes to its prices.